Douglas A Gray

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular evolutionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 08, 2021
What deubiquitinating enzymes, oncogenes, and tumor suppressors actually do: Are current assumptions supported by patient outcomes?

Sophie Gregoire-Mitha, Douglas A Gray

|Oct 11, 2019
Metformin Abrogates Age-Associated Ovarian Fibrosis.

Curtis W McCloskey, David P Cook, Brendan S Kelly

|Sep 24, 2019
Deubiquitinating Enzymes in Model Systems and Therapy: Redundancy and Compensation Have Implications.

Sarah Zachariah, Douglas A Gray

|Mar 09, 2017
Reversible modulation of SIRT1 activity in a mouse strain.

Katherine V Clark-Knowles, Xiaohong He, Karen Jardine

Pageof 1